Check the offer
When an offer needs a closer look
You do not have to prove a whole website right or wrong. Start with the claims that can be checked.
| What the offer says | What to check |
|---|---|
| No prescription needed Federal law, as checked on September 26, 2026, bars dispensing prescription drugs without a valid prescription. | A real assessment Ask who assesses you and who can answer questions about the proposed treatment. |
| A compounded product is approved “FDA-approved” is an untrue claim for a compounded medicine, according to the check on September 26, 2026; FDA means Food and Drug Administration. | The exact product Ask whether this is an approved manufactured product or a compounded preparation. |
| Research use only A “research use only” label is a reason to pause a treatment purchase. In warning letters checked on September 26, 2026, FDA challenged sellers offering research-labelled products for people to inject. Those labels did not make the sellers’ treatment claims acceptable. | The route into care Keep the discussion with a licensed prescriber and ask about an approved medicine. |
A polished page cannot answer the licence question
The U.S. Federal Trade Commission cautions that a health site’s seals and logos can be fake despite an official appearance.
Use the public records linked in the licence guide. Ask for the preparing or dispensing pharmacy’s name, rather than trying to infer it from a service logo.
FDA found labels on fraudulent compounded tirzepatide and semaglutide products that identified nonexistent pharmacies.
Keep price in context
FDA flags discounts that seem implausibly large; a low price by itself does not establish that an offer is wrong.
Ask which kind of price it is and which product it covers. Compare the price with the written terms, the licence record and the care process.
Leave with a question you can resolve
If a service will not explain the product or care process, pause. A useful next step is to discuss the unresolved point with a licensed clinician or ask the relevant board about a public record.